{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:47:58Z","timestamp":1784641678153,"version":"3.55.0"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Pediatric adrenocortical hyperplasias are rare; they usually present with Cushing syndrome (CS); of them, isolated micronodular adrenal disease and its variant, primary pigmented adrenocortical disease are the most commonly encountered. Most cases are due to defects in the cyclic AMP\/protein kinase A (cAMP\/PKA) pathway, although a few cases remain without an identified genetic defect. Another cause of adrenal hyperplasia in childhood is congenital adrenal hyperplasia, a group of autosomal recessive disorders that affect steroidogenic enzymes in the adrenal cortex. Clinical presentation varies and depends on the extent of the underlying enzymatic defect. The most common form is due to 21-hydroxylase deficiency; it accounts for more than 90% of the cases. In this article, we discuss the genetic etiology of adrenal hyperplasias in childhood.<\/jats:p>","DOI":"10.3389\/fendo.2022.937793","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T05:29:18Z","timestamp":1659504558000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Adrenal hyperplasias in childhood: An update"],"prefix":"10.3389","volume":"13","author":[{"given":"Georgia","family":"Pitsava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"B1","article-title":"Adrenocortical tumors and hyperplasias in childhood\u2013etiology, genetics, clinical presentation and therapy","volume":"4","author":"Sutter","year":"2006","journal-title":"Pediatr Endocrinol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yapd.2021.05.015","article-title":"Adrenal tumors in childhood","volume":"68","author":"Fuqua","year":"2021","journal-title":"Adv Pediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04339.x","article-title":"Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease","volume":"968","author":"Bourdeau","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2015.02.001","article-title":"Development of adrenal cortex zonation","volume":"44","author":"Xing","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1210\/mend.15.1.0585","article-title":"Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation","volume":"15","author":"Hanley","year":"2001","journal-title":"Mol Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4773(99)00307-X","article-title":"SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development","volume":"91","author":"Hanley","year":"2000","journal-title":"Mech Dev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25091","article-title":"In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development","volume":"116","author":"Goto","year":"2006","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(02)00602-1","article-title":"Recent insights into organogenesis of the adrenal cortex","volume":"13","author":"Keegan","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101448","DOI":"10.1016\/j.beem.2020.101448","article-title":"Pediatric adrenocortical tumours","volume":"34","author":"Pinto","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/er.2010-0001","article-title":"Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit","volume":"32","author":"Ishimoto","year":"2011","journal-title":"Endocr Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-861550","article-title":"The rise in adrenal androgen biosynthesis: adrenarche","volume":"22","author":"Havelock","year":"2004","journal-title":"Semin Reprod Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.4.4690","article-title":"Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation","volume":"83","author":"Yon","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(02)00609-4","article-title":"Dissecting human adrenal androgen production","volume":"13","author":"Rainey","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/frne.2001.0216","article-title":"DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology","volume":"22","author":"Labrie","year":"2001","journal-title":"Front Neuroendocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000149","article-title":"Protein kinase a defects and cortisol-producing adrenal tumors","volume":"22","author":"Zilbermint","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1210\/edrv.22.1.0420","article-title":"Ectopic and abnormal hormone receptors in adrenal cushing's syndrome","volume":"22","author":"Lacroix","year":"2001","journal-title":"Endocr Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2004.05.001","article-title":"What turns CREB on","volume":"16","author":"Johannessen","year":"2004","journal-title":"Cell Signal"},{"key":"B20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1749-6632.2002.tb04327.x","article-title":"Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues","volume":"968","author":"Rosenberg","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.10.006","article-title":"Carney Complex and other conditions associated with micronodular adrenal hyperplasias","volume":"24","author":"Almeida","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000134829","article-title":"Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent cushing syndrome)","volume":"13","author":"Stratakis","year":"2008","journal-title":"Endocr Dev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.02.008","article-title":"Cushing's syndrome in pediatrics: An update","volume":"47","author":"Lodish","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032247","article-title":"Cyclical cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity","volume":"89","author":"Gunther","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.4.3857","article-title":"Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy","volume":"82","author":"Sarlis","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Med (Baltimore)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-00956-3","article-title":"Predicting the risk of cardiac myxoma in Carney complex","volume":"23","author":"Pitsava","year":"2021","journal-title":"Genet Med"},{"key":"B28","article-title":"Genetics of adrenocortical tumors: Carney complex","volume":"62","author":"Stratakis","year":"2001","journal-title":"Ann Endocrinol (Paris)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase a type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.20.3037","article-title":"Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex","volume":"9","author":"Kirschner","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S44336","article-title":"Cushing's syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2402","article-title":"Diagnostic tests for children who are referred for the investigation of cushing syndrome","volume":"120","author":"Batista","year":"2007","journal-title":"Pediatrics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jpeds.2015.11.045","article-title":"Kidney stones as an underrecognized clinical sign in pediatric cushing disease","volume":"170","author":"Rahman","year":"2016","journal-title":"J Pediatr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.12.027","article-title":"Effects of cushing disease on bone mineral density in a pediatric population","volume":"156","author":"Lodish","year":"2010","journal-title":"J Pediatr"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2011.11.007","article-title":"Anthropometric measures and fasting insulin levels in children before and after cure of cushing syndrome","volume":"31","author":"Keil","year":"2012","journal-title":"Clin Nutr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2497","article-title":"Facial plethora: Modern technology for quantifying an ancient clinical sign and its use in cushing syndrome","volume":"100","author":"Afshari","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","article-title":"Cushing syndrome in pediatrics","volume":"41","author":"Stratakis","year":"2012","journal-title":"Endo Metab Clin North America"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.9.6817","article-title":"Linear growth and final height after treatment for cushing's disease in childhood","volume":"85","author":"Lebrethon","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.4.7962277","article-title":"Final stature in patients with endogenous cushing's syndrome","volume":"79","author":"Magiakou","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1090158","article-title":"Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of cushing's syndrome","volume":"109","author":"Bruno","year":"1985","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0031","article-title":"The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase a catalytic subunits","volume":"94","author":"Louiset","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199109263251301","article-title":"Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of cushing's syndrome","volume":"325","author":"Oldfield","year":"1991","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","article-title":"Adrenocortical hyperplasia: A multifaceted disease","volume":"34","author":"Bourdeau","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1123","article-title":"Phosphodiesterases in endocrine physiology and disease","volume":"165","author":"Vezzosi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2011.10.003","article-title":"Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment","volume":"11","author":"Levy","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1076694","article-title":"Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions","volume":"40","author":"Boikos","year":"2008","journal-title":"Horm Metab Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2914","article-title":"Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population","volume":"66","author":"Horvath","year":"2006","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2018.07.005","article-title":"Genetics of micronodular adrenal hyperplasia and Carney complex","volume":"47","author":"Tirosh","year":"2018","journal-title":"Presse Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04366.x","article-title":"Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours","volume":"77","author":"Rothenbuhler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31821ec4ce","article-title":"Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-albright syndrome","volume":"35","author":"Carney","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0648","article-title":"Genetics of adrenal tumors associated with cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias","volume":"3","author":"Stratakis","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-3-12","article-title":"McCune-albright syndrome","volume":"3","author":"Dumitrescu","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0062","article-title":"Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"91","author":"Moran","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1383","article-title":"Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"95","author":"Bidet","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","first-page":"625105","DOI":"10.1186\/1687-9856-2010-625105","article-title":"Nonclassic congenital adrenal hyperplasia","volume":"2010","author":"Witchel","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"B64","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am J Hum Genet"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.46","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US ashkenazi jews and caucasians","volume":"19","author":"Hannah-Shmouni","year":"2017","journal-title":"Genet Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.593315","article-title":"Congenital adrenal hyperplasias presenting in the newborn and young infant","volume":"8","author":"Balsamo","year":"2020","journal-title":"Front Pediatr"},{"key":"B67","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000488034","article-title":"Monogenic disorders of adrenal steroidogenesis","volume":"89","author":"Baranowski","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.10.008","article-title":"Nonclassic congenital adrenal hyperplasia: What do endocrinologists need to know","volume":"50","author":"Jha","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1067\/mpd.2001.110527","article-title":"Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis","volume":"138","author":"Eugster","year":"2001","journal-title":"J Pediatr"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199701000-00005","article-title":"Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height","volume":"41","author":"Jaaskelainen","year":"1997","journal-title":"Pediatr Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1651-2227.1995.tb13789.x","article-title":"Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood","volume":"84","author":"Yu","year":"1995","journal-title":"Acta Paediatr"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.770782","article-title":"Disorders of sex development of adrenal origin","volume":"12","author":"Finkielstain","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/BF01954521","article-title":"Influence of upright activity on plasma renin activity and aldosterone concentration in children","volume":"153","author":"Fukushige","year":"1994","journal-title":"Eur J Pediatr"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx014","article-title":"Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women","volume":"23","author":"Carmina","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.02.002","article-title":"Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic","volume":"165","author":"Auchus","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30267-6","article-title":"17 alpha-hydroxylation deficiency","volume":"20","author":"Biglieri","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(08)70021-5","article-title":"The genetics, pathophysiology, and management of human deficiencies of P450c17","volume":"30","author":"Auchus","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12834","article-title":"Characterization of the molecular genetic pathology in patients with 11beta-hydroxylase deficiency","volume":"83","author":"Mooij","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0279","article-title":"MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis","volume":"179","author":"Miller","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-01835-3","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase type 2 deficiency","volume":"63","author":"Al Alawi","year":"2019","journal-title":"Endocrine"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00208","article-title":"Longitudinal assessment of illnesses, stress dosing, and illness sequelae in patients with congenital adrenal hyperplasia","volume":"103","author":"El-Maouche","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jsbmb.2016.03.009","article-title":"Disorders in the initial steps of steroid hormone synthesis","volume":"165","author":"Miller","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612193352503","article-title":"The pathophysiology and genetics of congenital lipoid adrenal hyperplasia","volume":"335","author":"Bose","year":"1996","journal-title":"N Engl J Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1323","article-title":"A genetic isolate of congenital lipoid adrenal hyperplasia with atypical clinical findings","volume":"90","author":"Chen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119284","article-title":"Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene","volume":"99","author":"Fujieda","year":"1997","journal-title":"J Clin Invest"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.1998.11.6.707","article-title":"Molecular and clinical characterization of Korean patients with congenital lipoid adrenal hyperplasia","volume":"11","author":"Yoo","year":"1998","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2001.3202","article-title":"Molecular and structural analysis of two novel StAR mutations in patients with lipoid congenital adrenal hyperplasia","volume":"73","author":"Achermann","year":"2001","journal-title":"Mol Genet Metab"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.10.3636","article-title":"Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia","volume":"85","author":"Bose","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.4.571","article-title":"Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia","volume":"6","author":"Nakae","year":"1997","journal-title":"Hum Mol Genet"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0874","article-title":"A novel mutation L260P of the steroidogenic acute regulatory protein gene in three unrelated patients of Swiss ancestry with congenital lipoid adrenal hyperplasia","volume":"90","author":"Flu\u0308ck","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1126\/science.7892608","article-title":"Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis","volume":"267","author":"Lin","year":"1995","journal-title":"Science"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0190227","article-title":"Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein","volume":"19","author":"Miller","year":"1997","journal-title":"J Mol Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01661","article-title":"Characterization of the CYP11A1 nonsynonymous variant p.E314K in children presenting with adrenal insufficiency","volume":"104","author":"Kolli","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin Perinatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.937793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T05:29:23Z","timestamp":1659504563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.937793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":94,"alternative-id":["10.3389\/fendo.2022.937793"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.937793","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"article-number":"937793"}}